Ikena Oncology Ownership | Who Owns Ikena Oncology?

Ikena Oncology Ownership Summary

Ikena Oncology is owned by 30.32% institutional investors, 4.55% insiders, and 65.13% retail investors. Atlas venture life science advisors is the largest institutional shareholder, holding 10.40% of IKNA shares. Worldwide Healthcare Ord is the top mutual fund, with 3.37% of its assets in Ikena Oncology shares.

IKNA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ikena Oncology	30.32%	4.55%	65.13%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Atlas venture life science advisors	5.02M	10.40%	$8.23M
Blue owl capital lp	4.09M	8.48%	$6.71M
Bvf inc/il	4.01M	8.30%	$6.57M
Bml capital management	3.59M	7.43%	$5.88M
Orbimed advisors	3.54M	7.33%	$5.80M
Omega fund management	2.25M	4.66%	$3.71M
Gilead sciences	2.01M	4.16%	$3.29M
Vanguard group	1.38M	2.87%	$2.27M
Adage capital partners gp	800.00K	1.66%	$1.31M
Nea management company	600.06K	1.24%	$984.10K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	3.59M	3.65%	$5.88M
Omega fund management	2.25M	2.75%	$3.71M
Blue owl capital lp	4.09M	1.55%	$6.71M
Atlas venture life science advisors	5.02M	1.00%	$8.23M
Deuterium capital management	80.58K	0.35%	$132.15K
Bvf inc/il	4.01M	0.22%	$6.57M
Gilead sciences	2.01M	0.21%	$3.29M
Vazirani asset management	25.00K	0.13%	$41.00K
Orbimed advisors	3.54M	0.12%	$5.80M
Nea management company	600.06K	0.06%	$984.10K

Top Buyers

Holder	Shares	% Assets	Change
Bml capital management	3.59M	3.65%	2.86M
Gilead sciences	2.01M	0.21%	2.01M
Jpmorgan chase	155.74K	-	154.89K
Citadel advisors	244.69K	0.00%	85.67K
Ubs group	71.86K	-	71.78K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	354.84K	-	-1.47M
Bvf inc/il	4.01M	0.22%	-762.60K
Acuitas investments	-	-	-449.66K
State street	80.35K	-	-402.29K
Fny investment advisers	-	-	-231.38K

New Positions

Holder	Shares	% Assets	Change	Value
Gilead sciences	2.01M	0.21%	2.01M	$3.29M
Bnp paribas arbitrage, snc	44.04K	-	44.04K	$72.23K
Aqr capital management	21.86K	0.00%	21.86K	$36.07K
Engineers gate manager lp	18.93K	0.00%	18.93K	$31.05K
Cubist systematic strategies	4.84K	0.00%	4.84K	$7.99K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-3.00
Royal bank of canada	-707.00
Amalgamated bank	-717.00
Cwm	-985.00
Ameritas investment partners	-1.75K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	29	-49.12%	14,632,033	-48.49%	30	0.88%	9	-50.00%	9	-52.63%
Sep 30, 2024	57	-16.18%	28,407,567	-2.06%	58	1.63%	19	-53.66%	19	5.56%
Jun 30, 2024	68	21.43%	29,003,651	-3.64%	60	1.16%	41	57.69%	18	5.88%
Mar 31, 2024	56	3.70%	30,097,828	-7.07%	72	1.30%	26	-23.53%	17	41.67%
Dec 31, 2023	54	-6.90%	32,386,521	-0.99%	74	1.08%	34	-	12	33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Worldwide Healthcare Ord	1.63M	3.37%	-
Vanguard Total Stock Mkt Idx Inv	1.05M	2.18%	-
Vanguard US Total Market Shares ETF	1.05M	2.18%	-
Vanguard Institutional Extnd Mkt Idx Tr	318.15K	0.66%	-
Fidelity Extended Market Index	167.11K	0.35%	-1.06K
Bridgeway Ultra-Small Company Market	100.00K	0.21%	-
NT R2000 Value Index Fund - NL	87.83K	0.18%	18.26K
NT R2000 Index Fund - NL	77.70K	0.16%	-9.21K
Northern Trust Russell 2000 Value Index	64.58K	0.13%	855.00
NT R2000 Value Index Fund - L	64.58K	0.13%	855.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 24, 2022	ORBIMED ADVISORS LLC	-	Sell	$288.27K
Jun 23, 2022	ORBIMED ADVISORS LLC	-	Sell	$86.88K
Jun 22, 2022	ORBIMED ADVISORS LLC	-	Sell	$237.16K
Jun 22, 2022	OrbiMed Genesis GP LLC		Sell	$237.16K
Jun 24, 2022	ORBIMED ADVISORS LLC	-	Sell	$515.71K

Insider Transactions Trends

Date	Buy	Sell
2024 Q1	-	-
2023 Q3	-	-
2023 Q2	-	-
2023 Q1	-	-
2022 Q4	-	-

IKNA Ownership FAQ

Who Owns Ikena Oncology?

Ikena Oncology shareholders are primarily institutional investors at 30.32%, followed by 4.55% insiders and 65.13% retail investors. The average institutional ownership in Ikena Oncology's industry, Biotech Stocks , is 68.48%, which Ikena Oncology falls below.

Who owns the most shares of Ikena Oncology?

Ikena Oncology’s largest shareholders are Atlas venture life science advisors (5.02M shares, 10.40%), Blue owl capital lp (4.09M shares, 8.48%), and Bvf inc/il (4.01M shares, 8.30%). Together, they hold 27.18% of Ikena Oncology’s total shares outstanding.

Does Blackrock own Ikena Oncology?

BlackRock is not among the top 10 institutional shareholders of Ikena Oncology.

Who is Ikena Oncology’s biggest shareholder by percentage of total assets invested?

Bml capital management is Ikena Oncology’s biggest shareholder by percentage of total assets invested, with 3.65% of its assets in 3.59M Ikena Oncology shares, valued at 5.88M$.

Who is the top mutual fund holder of Ikena Oncology shares?

Worldwide Healthcare Ord is the top mutual fund holder of Ikena Oncology shares, with 3.37% of its total shares outstanding invested in 1.63M Ikena Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools